Check all documented drug-to-drug interactions. Major, moderate, and minor interactions with descriptions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Zemplar. Always confirm against the full prescribing information.
100 interactions
Aluminum hydroxide
The serum concentration of Aluminum hydroxide can be increased when it is combined with Paricalcitol.
Level 1 evidence
Apalutamide
The serum concentration of Paricalcitol can be decreased when it is combined with Apalutamide.
Level 1 evidence
Aprepitant
The metabolism of Paricalcitol can be decreased when combined with Aprepitant.
Level 2 evidence
Avanafil
The serum concentration of Avanafil can be increased when it is combined with Paricalcitol.
Level 1 evidence
Beclomethasone dipropionate
The therapeutic efficacy of Paricalcitol can be decreased when used in combination with Beclomethasone dipropionate.
Level 1 evidence
Bendroflumethiazide
The risk or severity of hypercalcemia can be increased when Bendroflumethiazide is combined with Paricalcitol.
Level 2 evidence
Berotralstat
The metabolism of Paricalcitol can be decreased when combined with Berotralstat.
Level 2 evidence
Betamethasone
The therapeutic efficacy of Paricalcitol can be decreased when used in combination with Betamethasone.
Level 1 evidence
Budesonide
The therapeutic efficacy of Paricalcitol can be decreased when used in combination with Budesonide.
Level 1 evidence
Calcifediol
The risk or severity of adverse effects can be increased when Calcifediol is combined with Paricalcitol.
Level 2 evidence
Calcitriol
The risk or severity of adverse effects can be increased when Calcitriol is combined with Paricalcitol.
Level 2 evidence
Calcium
The risk or severity of adverse effects can be increased when Paricalcitol is combined with Calcium.
Level 1 evidence
Enter your NPI to unlock 17 major interactions for Zemplar
Zemplar (Paricalcitol) has 178 documented drug interactions. Always review the full list with a pharmacist before co-prescribing.
Zemplar (Paricalcitol) has 37 major, 132 moderate, and 9 minor documented interactions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Zemplar. Always confirm against the full prescribing information.